DTAB to review 19 fixed-dose combinations drugs, codeine formulations today

CDSCO aims to phase out these combinations and codeine-based drugs in a phased manner

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing

Sohini Das Mumbai
The Drugs Technical Advisory Board (DTAB) is likely to meet on Monday to decide the fate of 19 fixed-dose combinations (FDCs) drugs that are considered 'irrational combinations'.  

Some of the common medicine brands which are under the scanner include cough syrup Ascoril C, TeddyKoff, and some cold medicines like D'Cold Total, Dolo Cold, headache medicines like Saridon etc.

The drugmakers have been asked to generate additional data on these drugs through phase-4 trials (trials done after marketing approval). The Drugs Controller General of India (DCGI) feels that additional data is required for these drugs, and thus pharma companies have been

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 26 2022 | 10:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com